European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)

iData Research, October 2009, Pages: 102

The European market, as defined in this report, encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden, and Norway), Portugal, Austria, and Switzerland. Additional products included in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal stents.

Keywords:
Cardiology, Interventional Cardiology, Europe, U.K., Germany, France, Belgium, Netherlands, Luxemburg, Sweden, Finland, Norway, Denmark, Austria, Switzerland, Italy, Spain, Portugal, Drug Eluting Stents, Bare Metal Stents, Guidewires, Catheters, Embolic Protection, atherectomy, IVUS catheters, catheters, optical coherence tomography, OCT, vulnerable plaque screening, PFO, patent foreman ovale, atrial septal defect, ASD, VSD, ventricular septal defect, PMVR, percutaneous mitral valve repair,

RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA'S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
2.1 INTRODUCTION
2.2 CURRENCY EXCHANGE RATES
2.3 EFFECTS OF THE ECONOMIC CRISIS

COUNTRY PROFILES
3.1 INTRODUCTION
3.1.1 Population
3.1.2 GDP per Capita
3.1.3 PCI and DES Penetration Rates
3.1.4 Price Index
3.2 GERMANY
3.3 FRANCE
3.4 UNITED KINGDOM
3.5 ITALY
3.6 SPAIN
3.7 BENELUX
3.8 SCANDINAVIA
3.9 PORTUGAL
3.10 AUSTRIA
3.11 SWITZERLAND

BARE-METAL AND DRUG-ELUTING STENTS
4.1 INTRODUCTION
4.2 OVERVIEW OF THE MARKET
4.2.1 Total Coronary Stent Market
4.2.2 Bare-Metal versus Drug-Eluting Stents
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Bare-Metal Stent Market
4.3.1.1 Market Analysis and Forecast
4.3.1.2 Bare-Metal Stent Market Drivers
4.3.1.3 Bare-Metal Stent Market Limiters
4.3.1.4 Bare-Metal Stent Competitive Analysis
4.3.2 Drug-Eluting Stent Market
4.3.2.1 Market Analysis and Forecast
4.3.2.2 Drug-Eluting Stent Market Drivers
4.3.2.3 Drug-Eluting Stent Market Limiters
4.3.2.4 Drug-Eluting Stent Competitive Analysis
4.3.3 Stents in Development
4.3.3.1 Bioabsorbable Stents
4.3.3.2 Bifurcated Stents

ABBREVIATIONS

LIST OF FIGURES
RESEARCH METHODOLOGY
EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
Figure 2-1: Exchange Rates for the Euro (€), 2008
COUNTRY PROFILES
Figure 3-1: Country Indicators, 2008
BARE-METAL AND DRUG-ELUTING STENTS
Figure 4-1: Market for Coronary Stents by Type, Europe, 2005 – 2015 (€)
Figure 4-2: Market for Coronary Stents by Type, Europe, 2005 – 2015 (US$)
Figure 4-3: Market for Coronary Stents by Country, Europe, 2005 – 2015 (€)
Figure 4-4: Market for Coronary Stents by Country, Europe, 2005 – 2015 (US$)
Figure 4-5: Penetration Rate for Coronary Stents by Type, Units Sold, Europe, 2005 – 2015
Figure 4-6: DES Penetration by Country, Europe, 2005 – 2015
Figure 4-7: Market for Bare-Metal Stents by Country, Europe, 2005 – 2015 (€)
Figure 4-8: Market for Bare-Metal Stents by Country, Europe, 2005 – 2015 (US$)
Figure 4-9: Market Drivers and Limiters, Market for Bare-Metal Stents, Europe, 2008
Figure 4-10: Leading Competitors, Market for Bare-Metal Stents, Europe, 2008
Figure 4-11: Market for Drug-Eluting Stents by Country, Europe, 2005 – 2015 (€)
Figure 4-12: Market for Drug-Eluting Stents by Country, Europe, 2005 – 2015 (US$)
Figure 4-13: Market Drivers and Limiters, Market for Drug-Eluting Stents, Europe, 2008
Figure 4-14: Leading Competitors, Market for Drug-Eluting Stents, Europe, 200
Figure 4-15: Coronary Stent Platforms in Development, 2008
Figure 4-16: Potential Market for Bioabsorbable Stents, Europe, 2010 – 2015 (€)
Figure 4-17: Potential Market for Bioabsorbable Stents, Europe, 2010 – 2015 (US$)
Figure 4-18: Potential Market for Bifurcated Stents, Europe, 2010 – 2015 (€)
Figure 4-19: Potential Market for Bifurcated Stents, Europe, 2010 – 2015 (US$)
ABBREVIATIONS

LIST OF CHARTS
RESEARCH METHODOLOGY
EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
COUNTRY PROFILES
Chart 3-1: German Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-2: French Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-3: The U.K. Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-4: Italian Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-5: Spanish Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-6: Beneluxian Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-7: Scandinavian Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-8: Portuguese Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-9: Austrian Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-10: Swiss Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
BARE-METAL AND DRUG-ELUTING STENTS
Chart 4-1: Market for Coronary Stents by Type, Europe, 2005 – 2015 (€)
Chart 4-2: Penetration Rate for Coronary Stents by Type, Units Sold, Europe, 2005 – 2015
Chart 4-3: Market for Bare-Metal Stents, Europe, 2005 – 2015 (€)
Chart 4-4: Leading Competitors, Market for Bare-Metal Stents, Europe, 2008
Chart 4-5: Market for Drug-Eluting Stents, Europe, 2005 – 2015 (€)
Chart 4-6: Leading Competitors, Market for Drug-Eluting Stents, Europe, 2008
Chart 4-7: Penetration Rate for Bioabsorbable Stents, Europe, 2010 – 2015
Chart 4-8: Penetration Rate for Bifurcated Stents, Europe, 2010 – 2015
ABBREVIATIONS

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

• Coronary Stents - Global Strategic Business Report
• Gene Amplification Technologies - Global Strategic Business Report
• Probiotics - Global Strategic Business Report
• Proteomics - Global Strategic Business Report
• Global Biopharmaceutical Market Report & Forecast (2012-2017)
• RNA Interference (RNAi) - Global Strategic Business Report
• Biotechnology Instrumentation - Global Strategic Business Report
• Agricultural Biotechnology - Global Strategic Business Report
• Molecular Cytogenetics - Global Strategic Business Report
• Growth Factors (Blood And Tissue) - Global Business Strategic Report